AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2016
May 10, 2016
34975_dirs_2016-05-10_3d9eb50c-d825-4c8f-8405-d0b9fee76bc5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2016-05-06
Reporting Person: Gagnon Robert E. (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-06 | Common Stock | A | 88652 | $0.00 | Acquired | 153897 | Direct |
| 2016-05-06 | Common Stock | A | 88652 | $0.00 | Acquired | 242549 | Direct |
Footnotes
F1: Represents a deferred stock award of 88,652 restricted stock units which shall vest in four equal installments on January 1, 2017, 2018, 2019 and 2020.
F2: Includes (a) a deferred stock award of 88,652 restricted stock units which shall vest in four equal installments on January 1, 2017, 2018, 2019 and 2020; (b) a deferred stock award of 19,875 restricted stock units which shall vest in three equal installments on January 1, 2017, 2018 and 2019; (c) a deferred stock award of 28,117 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (d) 17,253 shares of common stock held by the Reporting Person.
F3: Represents a deferred stock award of 88,652 restricted stock units which shall vest in full on May 6, 2018.
F4: Includes (a) a deferred stock award of 88,652 restricted stock units which shall vest in full on May 6, 2018; (b) a deferred stock award of 88,652 restricted stock units which shall vest in four equal installments on January 1, 2017, 2018, 2019 and 2020; (c) a deferred stock award of 19,875 restricted stock units which shall vest in three equal installments on January 1, 2017, 2018 and 2019; (d) a deferred stock award of 28,117 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 17,253 shares of common stock held by the Reporting Person.